Pharmaceutically useful salts of carboxylic acid derivatives
    1.
    发明申请
    Pharmaceutically useful salts of carboxylic acid derivatives 审中-公开
    羧酸衍生物的药用盐

    公开(公告)号:US20060142389A1

    公开(公告)日:2006-06-29

    申请号:US10560657

    申请日:2004-06-16

    IPC分类号: A61K31/205 C07C229/34

    CPC分类号: C07C235/20 C07B2200/07

    摘要: A compound selected from one or more of the following: a (1R,2S)-2-hydroxyindan-1-amine salt of (2S)-2-ethoxy-3-(4-{2-[hexyl(2-phenylethyl)amino]-2-oxoethoxy}phenyl)propanoic acid; an L-arginine salt of (2S)-2-ethoxy-3-(4-{2-[hexyl(2-phenylethyl)amino-2-oxoethoxyphenyl)propanoic acid; a tert-butylamine salt of (2S)-2-ethoxy-3-(4-{2-[hexyl(2-phenylethyl)amino-2-oxoethoxyphenyl)propanoic acid; a choline salt of (2S)-2-ethoxy-3-(4-{2-[hexyl(2-phenylethyl)amino]-2-oxoethoxy}phenyl)propanoic acid; an adamantylamine salt of (2S)-2-ethoxy-3-(4-{2-[hexyl(2-phenylethyl)amino]-2-oxoethoxy}phenyl)propanoic acid; a N-benzyl-2-phenylethanaminium salt of (2S)-2-ethoxy-3-(4-{2-[hexyl(2-phenylethyl)amino]-2-oxoethoxy}phenyl)propanoic acid; a N-benzyl-2-(benzylamino) ethanaminium salt of (2S)-2-ethoxy-3-(4-{2-[hexyl(2-phenylethyl)amino]-2-oxoethoxy}phenyl)propanoic acid; or a tris(hydroxymethyl)methylamine salt of (2S)-2-ethoxy-3-(4-{2-[hexyl(2-phenylethyl)amino]-2-oxoethoxy}phenyl)propanoic acid.

    摘要翻译: 选自下列一种或多种的化合物:(2S)-2-乙氧基-3-(4- {2- [己基(2-苯基乙基) 氨基] -2-氧代乙氧基}苯基)丙酸; (2S)-2-乙氧基-3-(4- {2- [己基(2-苯基乙基)氨基-2-氧代乙氧基苯基)丙酸的L-精氨酸盐; (2S)-2-乙氧基-3-(4- {2- [己基(2-苯基乙基)氨基-2-氧代乙氧基苯基)丙酸的叔丁基胺盐; (2S)-2-乙氧基-3-(4- {2- [己基(2-苯基乙基)氨基] -2-氧代乙氧基}苯基)丙酸的胆碱盐; (2S)-2-乙氧基-3-(4- {2- [己基(2-苯基乙基)氨基] -2-氧代乙氧基}苯基)丙酸的金刚烷基胺盐; (2S)-2-乙氧基-3-(4- {2- [己基(2-苯基乙基)氨基] -2-氧代乙氧基}苯基)丙酸的N-苄基-2-苯基乙胺盐; (2S)-2-乙氧基-3-(4- {2- [己基(2-苯基乙基)氨基] -2-氧代乙氧基}苯基)丙酸的N-苄基-2-(苄基氨基)乙胺盐; 或(2S)-2-乙氧基-3-(4- {2- [己基(2-苯基乙基)氨基] -2-氧代乙氧基}苯基)丙酸的三(羟甲基)甲胺盐。

    New Salt
    4.
    发明申请
    New Salt 审中-公开
    新盐

    公开(公告)号:US20070203137A1

    公开(公告)日:2007-08-30

    申请号:US11670681

    申请日:2007-02-02

    IPC分类号: A61K31/5377 C07D413/02

    CPC分类号: C07D401/04

    摘要: The present invention relates to a new pharmaceutically acceptable salt, the 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile citrate, a process for its preparation, pharmaceutical formulations containing said salt and to the use of said active salt in therapy, and particularly to GSK3 related conditions and disorders.

    摘要翻译: 本发明涉及一种新的药学上可接受的盐,2-羟基-3- [5-(吗啉-4-基甲基)吡啶-2-基] -1H-吲哚-5-甲酸柠檬酸盐,其制备方法,药物 含有所述盐的制剂和所述活性盐在治疗中的用途,特别是GSK3相关病症和病症。